Cargando…
TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway
SIMPLE SUMMARY: Acute myeloid leukemia (AML) remains an incurable hematological malignancy and patients have short survival due to AML relapse. In this study, we identified that TRIM10 was most downregulated in AML cell lines and AML patients. We further found that TRIM10 inhibits the growth of AML...
Autores principales: | Li, Lin, Li, Qi, Zou, Zhengrong, Huang, Zoufang, Chen, Yijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856727/ https://www.ncbi.nlm.nih.gov/pubmed/36672365 http://dx.doi.org/10.3390/cancers15020417 |
Ejemplares similares
-
Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)
por: Omsland, Maria, et al.
Publicado: (2016) -
Stabilization of NF-κB-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia
por: Xiu, Yan, et al.
Publicado: (2018) -
TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway
por: Yang, Weihong, et al.
Publicado: (2018) -
TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway
por: Zhou, Li, et al.
Publicado: (2019) -
TRIM14 promotes endothelial activation via activating NF-κB signaling pathway
por: Huang, Xuan, et al.
Publicado: (2019)